Andrew B. Sharabi
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 28
- Immunology top 2%
- Immunotherapy and Immune Responses 15
- Immune Cell Function and Interaction 7
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 6
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 12
-
- Lung Cancer Diagnosis and Treatment 7
-
- Advanced Radiotherapy Techniques 10
-
- Cervical Cancer and HPV Research 7
- Co-authors
- Charles G. DrakeTheodore L. DeWeeseMichael LimRazelle KurzrockShumei KatoAaron M. GoodmanDonald A. BarkauskasVighnesh Walavalkar
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Journal of Biological Chemistry (1 paper)Nature Communications (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesNetherlandsThailand
In The Last Decade
Andrew B. Sharabi
76 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 2.5k
- Immunology 1.3k
- Cancer Research 587
- Otorhinolaryngology 168
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Andrew B. Sharabi
This map shows the geographic impact of Andrew B. Sharabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew B. Sharabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew B. Sharabi more than expected).
Fields of papers citing papers by Andrew B. Sharabi
This network shows the impact of papers produced by Andrew B. Sharabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew B. Sharabi. The network helps show where Andrew B. Sharabi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew B. Sharabi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 34 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 34 | |
| 7 | 2021 | 13 | |
| 8 | 2020 | 53 | |
| 9 | 2020 | 141 | |
| 10 | 2020 | 47 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 37 | |
| 13 | 2019 | 46 | |
| 14 | 2018 | 67 | |
| 15 | Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Ratebreakdown → | 2017 | 648 |
| 16 | 2017 | 28 | |
| 17 | 2015 | 31 | |
| 18 | Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigenbreakdown → | 2014 | 510 |
| 19 | 2014 | 0 | |
| 20 | 2009 | 5 |
About Andrew B. Sharabi
Andrew B. Sharabi is a scholar working on Otorhinolaryngology, Oncology and Immunology, having authored 79 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (28 papers), Immunotherapy and Immune Responses (15 papers), Head and Neck Cancer Studies (12 papers), Advanced Radiotherapy Techniques (10 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cervical Cancer and HPV Research (7 papers), Immune Cell Function and Interaction (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.3k citations) and Cancer Research (587 citations). Andrew B. Sharabi has collaborated with scholars based in United States, Netherlands and Thailand. Frequent co-authors include Charles G. Drake, Theodore L. DeWeese, Michael Lim, Razelle Kurzrock, Shumei Kato, Aaron M. Goodman, Donald A. Barkauskas, Vighnesh Walavalkar, Vito Quaranta and Brian J. Francica. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.